Max Healthcare joins global consortium under Indo-European COMBAT initiative for dengue research

Max Healthcare Institute Ltd on Monday said it has joined an international consortium under the Indo-European COMBAT initiative to advance dengue research and strengthen pandemic preparedness. The initiative is supported by the Department of Biotechnology and the European Commission and brings together leading global and Indian institutions to develop technology-driven solutions for mosquito-borne disease management, Max Healthcare Institute said in a statement. The consortium has been awarded a landmark grant to drive this research programme, aimed at improving understanding, diagnosis, and management of dengue and related infectious diseases, it added. As dengue continues to pose a significant burden across tropical regions, the COMBAT initiative is expected to serve as a model for international collaboration, delivering scalable solutions while strengthening preparedness for future pandemics through innovation, data, and shared expertise, it added. Commeting on the development, Max Healthcare Group Medical Director, Sandeep Budhiraja said,''Dengue remains a significant public health challenge in India, and this collaboration enables us to combine clinical expertise with advanced technologies to improve early diagnosis and patient outcomes. It is a vital step toward building more resilient healthcare systems.'' Karolinska Institute, Associate Professor Ujjwal Neogi said the initiative brings together European scientific strength and India's clinical depth to develop data-driven, scalable solutions for infectious diseases. ''Such partnerships are critical to strengthening global preparedness for future health threats,'' Neogi added.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)